Franklin Genomic Advancements ETF
HELX
5 hedge funds and large institutions have $991K invested in Franklin Genomic Advancements ETF in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
400% more funds holding
Funds holding: 1 → 5 (+4)
36.76% less ownership
Funds ownership: 65% → 28.24% (-37%)
56% less capital invested
Capital invested by funds: $2.23M → $991K (-$1.24M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$256K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$202K |
| 3 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$146K |
| 4 |
CSPIA
Cary Street Partners Investment Advisory
Richmond,
Virginia
|
+$17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$1.87M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Franklin Resources
San Mateo,
California
| $351K | -$1.87M | -55,000 | -85% |
|
|
2
Jane Street
New York
| $264K | +$256K | +7,519 | New |
|
|
3
Commonwealth Equity Services
Waltham,
Massachusetts
| $207K | +$202K | +5,920 | New |
|
|
BFEC
4
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $151K | +$146K | +4,302 | New |
|
|
CSPIA
5
Cary Street Partners Investment Advisory
Richmond,
Virginia
| $18K | +$17K | +500 | New |
|
HELX Hedge Fund Activity: Q3 2020 in Review
5 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Franklin Genomic Advancements ETF (HELX) for Q3 2020, worth a combined $991K — down 56% from $2.23M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HELX positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $256K. The largest seller was Franklin Resources, cutting an estimated $1.87M.
- 5 institutional investors held Franklin Genomic Advancements ETF (HELX) as of Q3 2020, up from 1 in Q2 2020.
- Funds reported $991K of Franklin Genomic Advancements ETF stock for Q3 2020, down 56% quarter-over-quarter.
- 4 funds opened new Franklin Genomic Advancements ETF positions in Q3 2020 and 0 closed out, a net change of +4 holders.
- The largest Franklin Genomic Advancements ETF buyer in Q3 2020 was Jane Street, an estimated $256K added.
- The largest Franklin Genomic Advancements ETF seller in Q3 2020 was Franklin Resources, an estimated $1.87M sold.
Based on aggregated 13F filings for Q3 2020.